Company Filing History:
2 out of 15,543 
2 out of 900 
Years Active: 2022-2024
Title: The Innovative Contributions of Matthew Rettig
Introduction
Matthew Rettig is a notable inventor based in Los Angeles, California. He has made significant contributions to the field of cancer treatment through his innovative research and development of compounds targeting the androgen receptor.
Latest Patents
Matthew Rettig holds two patents related to inhibitors of the N-terminal domain of the androgen receptor. His latest patents provide compounds and methods for inhibiting or degrading this domain, which is crucial in the treatment of cancers such as prostate cancer. These advancements represent a promising approach to cancer therapy, potentially improving outcomes for patients.
Career Highlights
Throughout his career, Rettig has worked with prestigious institutions, including the University of California and the United States Government as represented by the Department of Veterans Affairs. His work in these organizations has allowed him to contribute to significant advancements in medical research and innovation.
Collaborations
Matthew Rettig has collaborated with esteemed colleagues, including Michael E. Jung and D. Elshan Nakath G. Ralalage. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in cancer treatment.
Conclusion
Matthew Rettig's contributions to the field of cancer research through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments, particularly for prostate cancer.